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INTRODUGrION 
One of the major problems of the dairy industry today is that of 
raising sound and healthy herd replacements. It is generally conceded 
that there is approximately a 25 per cent turnover annually in dairy 
herds. Ex:perienced dairymen prefer to raise their own replacements, 
since this has been proven to be the most profitable procedure in the 
long-run for obtaining the strong, healthy type of animal desired. The 
raising of calves is a complex problem which requires good sanitary feed-
ing and management practices by the dairyman. 
The most critical period in the life of' the dairy calf is probably 
the first f'our to eight weeks of life. It is during this period that the 
calf is very susceptible to diarrhea, pneumonia, and various other disorders. 
A. study by Herman (25) illustrates the importance of' good management 
of the young calf. In this work it was reported that a very high pe~ 
centage of calves died after birth unless they received colostrum. & long-
time study by Wing (66) revealed that of 644 calves born, 10.5% died under 
three months of age. & ten year average of the calf losses in the Cornell 
University dairy herd showed that 11% of the calves born in good condition 
soon died (53). Data from the Nebraska University dairy herd revealed 
that 14. 7% of' the calves died of disease during the first 2 years of life 
(17). It has been reported that th~re is a slightly higher mortality rate 
in female calves than in males (44). These studies illustrate the seri-
ousness of calf losses on American dairy farms and emphasizes the desira-
bility of developing calf raising methods which will produce stronger, 
more viable dairy calves. 
Various antibiotics have been supplemented to calf' rations in an 
attempt to produce an increased immunity and help the calf survive through 
the critical stages of early life. Such antibiotics as terramycin and 
aureomycin have been shown to have a favorable effect upon,dairy calves0 
As far as calf nutrition is concerned, aureomycin is the antibiotic under,, 
most intensive investigation by research workers at the present time. 
This antibiotic has been shown to reduce the severity and incidence 
of scours as well as to stimulate the growth rate of young calves. The 
definite mode of action of aureomycin in producing a favorable effect 
upon growth is not known. While it has been shown that oral administra-
/ 
tion of aureomycin is effective in reducing scours and stimulating growth, 
there is a question as to whether or not aureomycin might result in the 
same effect when given parenterallye 
The purpose of this trial was to study the effects of different 
levels of aureomycin when administered orally, subcutaneously and intra-
muscularly .. 
REVIEW OF LITERATURE 
The antibiotic aureomycin was first described by Duggar (19) in 
19480 It is derived from a species of the actinomycetes, which is 
designated Streptomyces aureofaciens and is an organism of the soil. 
The value of aureomycin as a chemotherapeutic agent in human medicine 
and as a growth stimulator in animal production has been investigated 
intensively during the past few years. 
Many research workers ( 2, 9, 26, 33, 34, J7, 39, 49, 50) have 
shown that small amounts of aureomycin is effective in stimulating the 
growth rate of dairy calves .. 
The Effect of Aureomycin Upon Dairy Calves 
McGilliard et al. (J7) observed that daily bodyweight gains were 
twice as great during the first five weeks of life for calves receiving 
70'mg. of aureomycin daily as compared to calves receiving no antibiotic. 
Loosli (34) reported that calves receiving aureomycin gained 22% more 
rapidly during the first eight weeks of life than calves which were not 
fed the antibiotic. The calves receiving aureomycin also required approx-
imately 9% less feed to make a unit of gain and exhibited a reduced 
incidence and severity of scours. Rusoff (49) found that aureoIIzy"cin 
stimulated the growth of 14 week old dairy calves by approximately J6% 
over the control animals for the first 6 weeks on trialo After 8 weeks 
the growth rate of the aureomycin fed calves decreased to 8% over controls 
and declined gradually until at the end of the 20 week experiment there 
was no difference in the total growth of calves receiving aureomycin and 
controls .. 
Murdock et al. (39) observed an increased gain in calves receiving 
aureomycin the first six weeks of life over calves not fed the antibiotic. 
3. 
By the end of 12 weeks there was no significant difference in weight 
gains between the two groups. These investigators reported no difference 
in the incidence of scouring. 
Morrison and Deal (38) obtained results that are not entirely in 
agreement with other studies. They observed no difference in weight 
gain, feed consumption, incidence of scours and general health in calves 
fed aureomycin at the rate of 1% of the dry matter content of the milk 
for two wee~s. The fact that small gains are made by calves the first 
two weeks, and that scours were not a problem in the experiment were 
offered as a possible explanation for these results. 
Bloom and Knodt (10) observed no great differences in the rate of 
bodyweight gains, in the consumption or utilization of feed by dairy 
calves when levels of' aureomycin ranging from 20 to 154 mg. were added 
daily to milk replacement formulas and to calf starter.s. 
Rusoff and Davis (48) reported that the growth of Jersey and Holstein 
calves through 16 weeks was increased approximately 20% over the controls 
by the feeding of aureomycin. The pure aureomycin prevented the onset of 
scours. Microscopic examination of the rumen contents failed to reveal 
any effect of aureomycin upon the flora of the rumene 
Bartley et !Y:.• (3) obtained an increase in the growth rate of calves 
when aurofac (containing 5 mgo of aureomycin per gram) was fed to the 
calves at the rate of 3 grams per 100 lbo bodyweight up to 12 weeks .. 
These workers reported a lower incidence of scours and a better physical 
condition in the calves receiving the aurofaco 
Voelker and Cason (60) reported more rapid gains in calves on pasture 
receiving an aureomycin -Biz supplement than control animalso No harm= 
ful effects were observed from the feeding of 250 mga of pure aureomycin 
daily plus 2o5% aurofac in the grain. Bacteriological studies of the 
4. 
colon material failErl to show any consistent differerlces in the popu~ 
lation of bacteri~ due to antibiotic feeding. 
Murley and associates (40) observed beneficial results in growth 
and efficiency of feed utilization by supplementing 80 mg. of crystal-
line aureomycin daily per head to young calves on various practical and 
restricted diets .. 
Clawson et alo (14) obtainErl greater gains in calves fed 80 mg. 
aureomycin HCl the first ten weeks of life than in calves not receiving 
the antibiotic. 
Hibbs and Conrad (26) found that feeding calves aureomycin up to 
12 weeks resulted in greater weight gains, higher feErl intake and more 
efficient utilization of feedo The calves receiving aureomycin main-
tained a higher blood sugar level than the controls from the eighth to 
the twelveth weeko 
Loosli and Wallace (32) obtainErl a significant increase in the 
growth rate of calves fed milk substitutes by the addition ~o the ration 
of either crystalline aureomycin HCl or an AP F supplement containing 
aureomycino Both the AP F and crystalline aureomycin were effective 
in reducing the severity and incidence of scours during the 8 week trial. 
It appeared that the antibiotic was responsible for the beneficial effects 
obtained since the aureomycin alone gave essentially the same results as 
the AP F supplemento Bloom and Knodt (9) also obtained beneficial 
results from feeding an aureomycin -B12 supplement in the milk replacement 
foX"l]llllas of dairy calveso These workers noted that the greatest increase 
in growth rate occurred during the first four weeks of life. They 
observed that pure B12 alone did not stimulate growtho MaeKay ~ alo 
(35) observed an increased growth in calves receiving a supplement con., 
taining aureomycin and vitamin B120 
5. 
Rusoff and Haq (50) found that, a vitamin B12 supplem~nt, (Mark's 
AP F No. J) had no apparent effect upqn the growth rate of dairy calves 
weaned from milf at four weeks. Tb.a AP F apparently contained little or 
no aureomycin. Williams and Knodt (E4) Qbserved no effect upon the 
growth rate of dairy calves fed an AP F supplement containing only 
slight amou:p.ts of aureomycin. 
A trial was conducted by Rusoff !i !l,. (51) to observe whether the 
type of pro'!;ein in an all vegetable protein calf' starter would influence 
the effect of aureomycin on young e.alves. The animals fed a soybean..oil,,.. 
meaJ.....proteiµ starter plus aureomycin showed greater ave-rage daily gains 
than calves receiving a cottonseed meal protein wi.th aureomycin.. The 
calves on each of the plant proteins showed a 10...20% increase in average 
daily gains when aureomycin was added to the ration. 
Jacobson !i !!,. (JO),fed aureomycin to four-month 014 calves» some 
of which had received 80 mg. of aureomycin ma from four d,ays of age, 
and others which had not received Jureomycin •. These calveis were fed 
80 mg. aureomycin (aurofac A) in their concentrate mixture daily for 
12 weeks. The aureomycin suppleme~ted calves exhibited significantly 
greater growth rates than the eontf()ls. Although previou$ treatment had 
less effect than experimental treat,ment on changes in weight and various 
body measurements, the mean values in all instances were greater for 
calves not previously supplemented with aureomycin. 
In a previous study by Jacobson (29) it had been demonstrated that 
the feeding or aureomycin and of an aureomycin supplement to c.alves up 
to 200 days or age resulted in increased growth by approxi.ID.$tely JO% 
above the Ragsdale sta:nd.ard. The weights of the control aalves at 200 
days were about equal to Ragsdale Standards. 
Finchman, and Voelke:r (22} fed aureomycin to dairy heifer; daily for 
6. 
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periods ranging up to approximatelr two and one-half yearij. They observed 
that the. maximum growth stimulatiop. from aureomycin fee diI).g occurred 
during the period from birth to s~ monthse Three laetat:i,ng heifers 
which had received aureomycin continually from four days qf age showed 
no abnormalaties nor advantages attributable to antibiotic feeding. 
Bartley ~ !!J:.~ (5) conducted studies in which the results indicated 
that the addition .. oi' a 1% level of Leder le I s Aurofae 2 A. in the grain 
ration of heifers from seven to sixteen months of age had no stimulatory 
effect upon growth. 
In some instances it has been shown that a decrease in growth rate 
occurs following the removal of aureo:myein from the ration of calves. 
Jacobson~ alo (29) reported a slight decrease in growth rate following 
removal of aureomycin from the ration of da:i,ry calves, but the decrease 
was not considered significant. Bartley and associates (3) also observed 
a decrease in growth rate in dairy calves when aureomycin supplement was 
removed f'rom the ration. These calves maintained their previous growth 
rate for one week after the antibioti$ had been removed from th~ dietJI 
indicating a carryover ef'feet. 
McGilliard ~ !lo (37) at the Oklahoma A & M Experiment Station 
found a slight decrease in growth rate following removal of aureomycin 
from the ration of calves at five weeks. This decrease in growth rate 
may have been due to some physiological disturbance or a readjustment of 
the microflora in the rumen to a different environment caused by the 
removal of aureomycin from the rationo These workers discovered that 
the decrease in growth rate was delayed by inoculating the calves with 
rumen material from mature animals. 
·1 
The administration of other antibiotics has resulted in growth 
responses similar to that observed with aureomycin.; Loo·sli (3.3) found 
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that an antibiotic supplemep.t (1.ederle) . added to milk x-eplacement formulas 
at the rate of 2% or fed in whole milk increased the average daily gain ot 
dairy calves. The control ~nimals exhibited a greater incidence and 
severity of scours and required more TDN per pound of ~in than the calves 
receiving antibiotics. 
Research workers (60, .36, 61) have obtained a growth stimulation in 
calves with the supplementation of terramycin to the ration. MaeKay. !i !!. 
(.36) found that this antibiotic exhibited its greatest growth stimulus 
during the first two weeks of life. A..fter eight weeks of feeding terramycin 
there was little difference observed in the rate of gain between supplemel'Ilial 
calves and controls. · 
The Effect of Aureomycin on other Domestic Animals 
Re seareh workers ( .34.1> 4, 24) have de·ilionstrat ed. that lactating cows 
were not affected by levels of 1.30 to 700 mg. aureomycin dailyo Loosli 
(34) reported that the addition of·lOOO mg. of aureomycin to the grain 
ration of cows resulted in complete refusal of the feed., It appeared that 
this amount of antibiotic rendered the feed decidely unpalatable. 
Newnan ~ !!,. (41) found no beneficial results from feeding low le~ls 
of aureomycin to yearling bee£ heifers. A reduction in appetite was noted 
for a few days after the feeding of aureomycin was begun, but no unfavor-
able physiological disturbances were observed. Bacteriological data 
'1revealed that the normal rumen mieroflora had been disturbed.. 
. Bell and associates (8) found that 200 mg. o:t aureomycin in the 
ration of st·eers ,caused a reduction in digestibility of dry matter and 
nitrogen tree extra'Cto Levels of 600 mg. produced a marked anorexia 
and diarrhea. These workers suggested that the antibiotic had a detrice 
mental effect upon the cellulolytic microo:rgansims. of .. the" rumen. 
Colby-~-~. (15) tound that lambs went entirely off feed and lost 
0.16 lb. bodyweight per day when fed 100 mg. of aureomycin daily. 
Chance and associates (12) studied the influence of aureomycin on 
rumen digestion and the rate of passage ot cert.sin nutrients from the 
rumen. In a trial with two rumen fistul.ated steers the data indicated 
that aureoDzy"cin stimulated bacterial action in the rumen and may have 
caused a change in the permeability of the rumen wall which would 
facilitate faster absorption in that area. The number of bacteria in 
the rumen increased when 500 mg. or aureomycin was added to the ration. 
The total bacteria count was the sam~ when 500 or 1000 mg. wer.e fed, but 
since there was a decrease in the removal of nutrients from the rwnen 
when 1000 mg. wer.e fed, it is possible that this level may have inhibited 
some of the cellulose digesting baeter.i.a without affecting the total 
count. These research workers (l;) also found a smaller concentration 
0£ the ten essential amino aeids in the rumen six hours after feeding 
500 mg. of aureallzy"cin. The data suggest that ingestion of 500 mg. of 
aureomycin accelerated the removal of amino acids from the rumen. The 
amount of riboflavin in the rumen was also found to- l:;>e lower on the 
aureomycin ration. Data indicated that the antibiotic caused a reduction 
in the synthesis of nicotinic acid in the rumen. 
This broad spectrum. antibiotic has also been shown to have a stim... 
ulatory effect upo~ the growth rate of animals other than calveso ln 
increased growth rat.a-- was obtained in chickens by the use of aureomycin 
and aureomycin supplements (45, 21). :aesearch workers (Z7, 59) have 
stimulated growth in rats and mice by the use of this antibiotic. 
Purdue workers (7, 43) have indicated that aureomyein stimulates the 
growth rate of growi.n-g· and fattening swine.. Gilts fed aureomycin 
farrowed more and heavier pigs· than gilts not receiving the antibiotic (58). 
Wallace ~ !J:,. (62) studied the ef'fects at redµ.eing the level ot 
aureomycin and its complete removal from the ra"'tion of fattening p:J;gs. 
They concluded that the antibiotic supplement should not be discontinued 
during the growing.,,£attening period 0£ pigs it opti~ gains are to 'be 
obtained. 
Wilson and associates ( 65) .f'ound that the percent lean cuts in hog 
carcasses was increased when aureomycin was added to low and medium 
protein diets. This increase was not observed when aureomycin was added 
to an 18% protein ration. 
Noland ~ !J:,. (42) produced an increased gain in weight by 11.3% in 
young pigs over the controls by the subcutaneous implantation 0£ baeitracin 
pellets. 
Becker ( 6) obtained a significant increase in rate of gain in pigs 
by the supplementation of aureomycin, neomycin, prooaine penicillin and 
ehlorampherdcol. 
Research workers (20, 1, 47) .found also that penicillin and ~erramyein 
produced an increase in the f;;rowth rate 0£ chickens. 
Theories Relative to the Mode of Action of Aureomycin 
The definite mode of action of aureomycin in s~imulating growth is 
not knowno Many theories have been offered as an explanation but as yet 
none have been proven. 
Many workers (16, 23, Zl ~ 28, 321 55, 59) have indicated that aureo-
mycin may produce its beneficial effect upon animals by some action upon 
the intestinal mierof'lora. 
Schoenbaeh ~ 11• (54) have shown with in vitro. studies that aureo-
mycin possesses bacteriostatte-and bactericidal activity against various 
gr8Jll :posi'tiie· aria· gram negative bacteria. · In treatment ot an infection 
10. 
in man, Friedberg (23) found aureomycin to have only a bacterlostatiG 
effect upon Streptococc~ feeali.§.e The antibiotic llj.erely inhibited these 
organisms when aureomyci.n wa13 present at high levelf! and the organisms 
regained ·their activity when the antibiotic concentration decreased. 
Sieburth and c0=oworkers (55) found that antibiotics inhibit the 
Clostridium perfr.tngens organism which has been shown to produce enter()... 
toxemia in sheep. These workers suggested that antibiotics may promote 
growth by the prevention of enterotoxemia., 
Elam ~ ~. (21) also demonstrated that antibiotics. de9reased the 
- ··-
number of clostrldia organisms in the cluck and subsequentl}' -~~~~~~s~d ,:_ __ 
growth. Previous work: (;Reyniers, Luckey and Gordon) had_ shown that anti-
biotics. did not increase growth of birds under gem. free eo:p.ditions, but 
antibiotics did increase growth of chicks maintained under ordinary 
laboratory conditions. 
Vijayaraghavan and associat,es (59) found that aureomycin had no 
effect. upon the growth rate of mice fed rations in which ease.in was the 
sole source or protein. An increase in growth rate.was observed when 
aureomycin was fed to mice receiving cottonseed meal and soybean meal as 
the sole dietary source of protein. These workers concluded, that since 
a positiv, respqnse of growth rate was obtained with plant :proteins it 
appeared possible that antibiotics may promote development pf the micro-
flora which enhance av.a:ilaQility of the intestinal synthesi~ of critical 
sm:i:no acids.. While this may be true9 . it has been shown tlla-p aureomycin 
stimulates the growth rate of young calves on milk diets in which the 
major protein consumed. is .not of plant origin. 
Rnsoff' ( 51) conducted a study of the intestinal mic:J:'.'Onor~ o;f young 
dairy calves receiving aureomycin.. He concluded that tlie ID.Qde of' ao'W.on 
o:t antibiotics in stimulating_cialf' growth .. apparently is no'.ti. du~-. to 
11. 
selective bacterial inhibition, of eemmon bacterial groups of the intestines. 
This coneul~on may be partially substantiated by the wrk of Stokstad and 
Jukes (56) in whioh they found that aureomycin still displayed growth,.. 
promoting activity after a sufficient treatment with alkali to destroy 
the antibacterial action against staph.yloeoccus aureus. 
The Effects of Antibiotics Administered Parenterally 
Although the mode of action of aureomycin in stinmlating growth is 
not known, it has been show th.at oral administration is eff'ective in 
increasing growth rate. There is a question as to whether or not 
' 
aureomycin would have the same effect if administered parente~ly. 
?here has been a limited amount of work conducted in which antibiotics 
were administered parenterally. Only one study is available with dairy 
calves, although several studies have been conducted with pigs and chickens. 
Results of contempora:ey investigations by B.ttso.tt and associates (52) 
showed that weekly intramuscmlar inj actions of 400 mg. of i:ureomyoin were 
effective in increasing the bodyweight gains of young dairy calves. These 
animals also showed greater gains over the controls than did calves 
reoe:µ. ving · 50 mg. daily of auree>myci:n by ore.l administration. 
Noland n fl,. (42) studied the effects 0£ baci traein when implanted 
subcutaneously in pellet form at the base of -the ear in two to :f'ive day. 
old. pigs. ~t the end of 56 days the implanted pigs had gained 11.3% more 
than the controls. 
Terrill and co-workers (57) concluded that the S11bcutaneous implan-
tati()n of either bacitracin1 penicillin or aureomycin pellets was not 
effective in increasing either the weaning weights of pigs or survival 
to weaning age. : 
El$Dl and eo-wo:rkers (20) ' observed an increase in. growth and a decrease 
in mortality of chi~ke:ns when penicillin was inj eeted intravenously .. 
Becker et ~o (6) found that int:ramus{fular injections of probm.ne 
penicillin G produced a statistically signi,ficant increase in rate of 
gain in pi gs., 
Studies are limited as to the effect of aureomycin upon dairy calves 
when given parenterally.. There has been observations made on humans, 
pigs and laboratory animals 1~eceiving aureomycin by parenteral admini.S= 
trationo 
Schoenbach and c0=,workers (54) observed that aureomycin injected 
intramuscularly into patients caused an acute pain lasting several 
minutes followed by a dull d:r,aw.ing pain which persisted for about one-
half hour., These workers discovered a high uI'inary concent,ra.tion of 
aureomycin after intramuscular injections, but difficulty was encountered 
in determining serum levels., 
Dowling ~ al. (18) also reported a stinging sensation in patients 
injected intra.muscularly with aureomycin. These workers found evidence 
by st~dying blood serum levels of aureomycin which indicated that 100 mg. 
of the antibiotic injected int1'8.museularly resulted in almost as high 
blood levels a.t the· end o.f 3 hours as 700 mg. giveh orally~ Welch (6.3) 
noted that aureomycin was absorbed rapidly from the gastro=intestinal 
tract and produced peak serum concentrations in approximately .four hours. 
Bryer and associates (11) found significant blood serum. levels of 
aureomycin in rabbits fifteen minutes to one hour followi11g intramuscular 
inj eetion of 20 mg. per ldlogr.am of bodyweight., No signi.ficant serum 
e·oncentration could be detected later than one hour after injection.. No 
antibiotic could be detected in the spinal flu.id after the parenteral 
admi.nistration., 
' R:o.bi0n:So1''ij (4-6) Btudi,es nth .man show that ~u.reomycin, while generally 
13, 
well tolerated, may produce eertain adverse effects. Gastro-intestinal 
disturbances including nausea, vomiting, loose stools, and (liarrhea, 
appear to be the :mpst comm.on side effects. ·~ 
Larson and Carpenter (31) studied the concentration 0f aureomycin 
in the feces of pigs after oral and parenteral administration. The 
antibiotic was found in the feces 24 hours after injection and reaehai 
.a peak within 72 hours. When aureomycin was given orally the maximum 
level in the feces was observed in 48 hours. These workers suggested 
that the inj acted aureomye>J.n reached the intei:rtiinal tract by way of' 
the bile., 
Cole (16) has shown that aureomycl.n is readily excreted into the 
gastro-intestinal tract after intravenous administration. The gastr.i.c 
contents were found to contain low amounts of aureomycin one hour af'ter 
administration and these concentrations seemed to be too high to be 
' 
accounted for on the basis or contamination with swallowed saliva. The 
duodenum contents were relatively high in concentrations of the antibiotiCJo. 
The bile appeared to provide the most concentrated source of aureomycin for 
excretion into the intestinal tract when it was given intra.venously. 
The above. study is supported. 'by Zaslow ( 671 68) who found levels of 
40.,So mcg., per mlo of aureomycin in the bile three hours after a single 
intra.venous dose of' 250 mg. These wrkers state that there is no doubt 
that intravenous dc;,ses as small as 25 mg. will give levels of aureomycin 
in the bile high enough to be effective against susceptible organisms. 
EXPERIMENTAL 
Various trials including a previous study at the Oklahoma A. & M. 
E:x.periment Station have show an increase in growth rate of' dairy calves 
. given aureom,cin by daily oral administration.. This trial was designed 
to study further the effects or dif'f'erent levels or oral administration 
as well as subcutaneous implantations and intranmseular injections. 
Male and female G'll.ernsey, Ayrshire, and Holstein calves f'rom the 
Oklahoma A. & Mo College dairy herd were used in this study. All calves 
were removed :from their dams 48 hours after birth and placed in individ-
ual tie-stalls for the duration of the trial. The stalls were bedded 
with sawdust and were cleaned daily. Each stall was equipped with a 
self-feeding ha1'raek, a grain bucket, and a water bucket. Fresh water 
was kept before the.calves at all times. 
The temperature of' the section of the college dairy barn in which 
the calves were housed was thermostatically con.trolled, The temperature 
was maintained at approximately- 65or. during the fall and winter when 
experiment I was in progress. Experiment II was conducted during the 
spring and summer and the temperature of the barn during this peri(!?d 
I 
ranged from 80 to 850Ji'. 
The calves were allotted to one ef five groups in which the initial 
b0dyweight and ntl.Dlber or calves of each breed was kept as nearly e~nstant 
as possible. All calves were fed a ration. which consisted of ane potm.d 
of Holstein herd milk per 12.5 lb. bodyweight daily fed by nipple pail 
and goad quality prairie hay and a 16% protein calf starter offered 
.s libi tum.. 
In the first of' two experiments, five groups of calves were treated 
as follows: Group A served as untreated controls; calves in group B 
were administered~~ a single capsule of 250 mg. crystalline 
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-aureomycin HCl per week., Tb.is group was included :in the experiment 
so that the effects of a weekly oral dose of the antibiotic might be 
studit?-d, 250 mg. wa.s arb:ttrarily c:hosen as the lE;rqel for this trialo 
Since previous 1,vm.'"k at, the Arkansas St,ation had shcnm beneficial 
results from the subie:ut,a:neous implanta:&ion. of bacitra.cin, it appeared 
desirable to subject a group of calves to a similar treatment with 
aureomycin. These animals were desigriated as group O and were implanted 
subcutaneously at the base of the ear ·with 60 mg o aure,mnyc:in hydro-
chloride pellets weeklye The pellets were appr0ximately Oo4 of a cmo 
in length and Oe25 of a cmo in dia:metere Each pelle·t contained 20 mg. 
of aureomyi::dn., The pellets were implanted just under the calf 8 s skin 
w:lth a stilbesterol implant gun.. Sixt,y mg. appeared t{J be the most 
reasonable dosage for a single implantation under the conditions of our 
study. Sixty mg. administered weekly by implant as compared to 250 Inge 
given orally is a lg4 ratio of parenteral to oral administration .. 
Results of' studies with humar1s indicated that this dosage ratio should 
result in ~omparable blood levelso 
Calves in g1•oup D were give:n a capsule conta:i.ning '70 mg. of 
crystalline aureomycin HCl by oral administration daily and were used as 
a raf"eren.ce group in orde1• t~ have a comparison between the present 
study and previous workQ 
In group Ethe calves we:re injected intramuscularly with 60 mg., 
aureoniycin weekly for c,)mparison with the implant,ed grou:po The injecrl.= 
able antibiotic consis·ted of a:n aureom.ycin=AlCl eomplex9 dispersed ir1 
sesame oil. 
Each group in experinJ.C·m·t I consisted of 4 Guernseys, 2 Ayrshires., 
and 1 HolsteJ.:ne There Wti:n"1e 4 fe:m.a.le and 3 male calves :ln gr<Yups A9 B9 
and E; group G9 6 females and 1 :male, group D, 4 :males and 3 females. 
Although the ini.tia.l weights were kept as nearly constant as possible, 
some deviations occu.rrede Group E had the highest initial weight of 
77 .'3 lb.; · group B had t,he lo·west beginning weight of 73.0 lb.; group C 
-i1a.s secw1d high w;lth "16.6 lb,; gr·(n:i.p D ims third high with. "14.1 lb .. ; 
f'ollowed by g1~oup A wi'th '7.3 .,4 lbo 
The study Yas co:ntirnJJ.ed in a sec9.nd experiment in which the levels 
of administration were aH,ered., G1·oups A and D were ct.>nt:inued as in 
experiment I to sei:ire as ccJntr,~1 and reference groups, respectively., 
Group F was added to study the etfect of a. higher le,rel of' 500 mg. 
aureomycin weekly in a single oral admi.niertrat;ion. By studying the 
results of groups D a:n.d l!,/) a comparison could be made be·t.ween a single 
weekly administration ef 500 mg. and 490 mg. given in 7 daily doses. 
In order to deter1nine whether or not calves would respond tc e·11·en 
lower amounts of' au.reomyc:it.1, another group, H, was added in which ea.lves 
received 125 mg. weekly i:n a. single oral dose. Group G was added to 
study a higher level of' intir•amuscular injection,, The calves in this 
group were injec·tad once a week with 250 mg. of' aureomycin (aureomycdn 
in sesame oil as ilCl eonrplex) • 
The calves in group A e:011.sisrted of 2 ma.le Guer"?lseys,, l f'e~le 
Guernsey and 1 female Holstein.. Group D had 2 ro.ale Guernseys, 2 :male 
Ayrshires; group F, 2 f'emale Guernseys, 1 male Guernsey, and 1 f'emale 
Holstein; group G, 2 :male Guernseys, 1 female Guernsey, and l female 
Ayrshire; group H, 2 ma.le Guenu;i~!iys and 2 rem.ale Ayrshire~. The ini.t:i,!ll 
weights varied from 79,,7 lb., :i.n group F to 71.7 lb. in group G. The 
average initial weights for the other groups -were as f(:lllows: group D, 
76.'7 lb.,, group A, '7'le5 lbo~ group H/) 74,.4 lb. 
The duration of each experiment was four ~eakso This appeared to 
be the most optiminn length !or the t1·ial since previous work has sho"!_n 
l? 
that the major response from aureomycin occurs during the first few weeks 
of life. The length of the e:xper~~nt also afforded an,. opportunity for 
a .maximum. nwnber of calves to be included in the study. 
The effects of the treatments in both fc:m.r week experiments were 
measured by records of feed consumption and gain in bodyweight, change in 
height at withers and change in chest circumference. The total increase 
in growth from the initial day of the experiment until the terminatien 
or the trial at four -weeks was used as the main criteria for determining 
the effects of the treatments •. The calves were weighed and measured 
weekly to d~termine whether or not growth rate was affected at any 
specific interval between the initial and terminal days of the study. 
The health and well=being of each animal was observed daily for the 
duration of the trialo In this study any looseness of the feces was 
considered as scours. The first treatment administered after the initial 
observation of seours was to cut the calf's daily allowance Qf milk in 
half .. If improvement was not noted 1n 24 hours following the reduction 
of milk intake,, ;oo mg. of aureomycin was givell by capsule. After 
sufficient recovery,, the milk intake was gradually increased baek to the 
original allowance before scouring occurred. 
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RESULTS 
The effects of oral and parenteral administration of aureonwein 
upon the growth and f 0eed consumptfom of the calves :in experiment I are 
su.mroarized in Table I., The d,ata relative to the individual calves by 
groups a.re presented in Appendix Tables l thr·ough 5.. The control calves 
i..'l'l group A gained an average of 11.4 pounds from birth tci four 'Weeks or 
age, which is an average daily gain of 0.40 pounds .. The calves in group D 
receiiving 70 mg. of aureomyein in a daily oral administration gained an 
average of" 15 pounds during the trial., This is a:n average daily gain of 
0.,53 pounds and is Oel3 of a potmd greed:;er than that of the control 
mdmals. 
The animals in group B I'e~eiving 250 mg e or aureomycin in a single 
weekly oral administration exhibited greater b@dy<..iE=Jdght gains than any 
of the other groups in experiment I., These ealv·es gained 15~8 pounds 
which is a11 average daily gain of Oo56 pounds. Groups D and B exhibited 
comparable growth responses over the control animals .. 
The cabres in group C rece:i.ving 60 mg. of aureomycin pellerts weekly 
by implant ma.de an average gain or 10.8 pounds for the four week trial. 
Animals in group E which were administered 60 mg., of aureomy~in weekly by 
intramuscular injecti0n ga:ined an a;verage of' 9.1 pou:ndso These two groups 
receiving aureomycin by parenteral administration obviously showed no 
beneffoial response f'rmn the a.ntibiCltie. Actually the calves :in these 
grtn1ps had somewhat l{lwer bod:;rweight gains than the controls., 
There was very little diff'erenice in the skeletal growth as measured 
by height at withers and chest circumference among all animals on triale 
There appeared to be a. tendency, however~ for a slightly greater skeletal 
growth in the animals receiving aureomycin by oral administration. 
Groups Band D had an average gain in height at ~ithers of 1~57 inches 
Table I 
The Effect of Aureomycin Administered Orally and Parenterally Upon 
Growth and Feed Gonsumption of Dairy Calves During the First 4 Weeks of Life, 
Experiment I 
Average growth gains by 4 weeks Average Feed Consumed. by 4 weeks 
Group1 Ave. Ave. Gain Ave. Gain A.veo Gain J.lilk Starter Hay · 
Initial in in Ht .. at in Chest 
Weight.. Bodyweight Withers Circum.f erenee 
(lb.) (lb:-) (inches) (inches) " (lb.) (lb.) {lbo) 
A 73o4 llo4 1.4 l.4 164.9 S.3 -4 .. 8 
B 73.0 15.9 1.6 1.9 165.4 5.9 5.2 
C 76.6 10.9 .9 1.4 153.9 5.6 4.6 
D 74.1 15.0 l.6 1.8 165.2 9.6 5.6 
E 77.3 9.l 1.0 1.4 166.0 5.2 4.6 
lEach group consisted of 4 Guernseys, 2 Ayrshires, and l Holstein. 
Group A., Control; B, 250 mg. aureomycin weekly by oral administration; C; ff) mg. implant weeklYJ D, 70 mg0 
daily by oral administration; Ei €JJ mg. weekly by intramuscular injection. 
N 
0 
0 
as compared to lo35 inches for the controls. Groups C and E had an average 
gain in height at withers of Oo92 and 1.00 inch,respectively. Calves :in 
gr01,1ps Band D gained 1.85 and 1.78 inches,respectively,in chest circUIIF 
ference as compared to 1.35 inches for the animals in groups A, c, and E. 
The average bodyweight gains for each group are represented graph-
ically in Figure I.. The growth curve as represented by gain in bodyweight 
was developed by plotting the average weekly gains in bodyweight for each 
· group from the initial to the terminal weighingo 
The control calves made an average gain of one pound the first 1two 
and one=half dayso They made no gains for the next seven days, but then 
displayed a relatively constant rate or gain for the remainder of the 
experiment but they never attained the increase in bodyweight observed 
in groups Band Do 
The animals in group D lost an average of 108 pounds during the 
first two and one=half days, but gained at a more rapid rate than calves 
in any of the other groups during the remainder of the trialo The low 
average of group D the first two and one=half days was largely due to the 
lOoO pound loss by Guernsey Noe 9 (a)o If the average change in body= 
weight for the other six calves in group D were used with Guernsey Noo 9 
(a) excluded the average loss would amount to less than one=half pound 
for the period. 
The calves in group B exhibited the most uniform growth curve of all 
the groups. These calves made up.iform gains from the initial day of the 
experiment and had the highest average gain of all groups when the study 
was terminatedo 
The implanted calves of group C made no appreciable gaµis during 
the first nine and one=half dayso The next fourteen days they gained an 
average of slightly over 6.0 pounds, whieh was less than either the 
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FIGURE I 
COMPARISON OF GROWTH AS MJ£ASURED 
BY AVE_. WEEKLY GAIN IN· BOD~EIGHT 
FROM THE INITIAL TO THE FitiAL WEIGHT. 
control calves or the calves receiving oral administrations of aureo-
D\YCin during the same period. The rate of gain of the animals in group C 
increased abovd that observed in the controls during the last four and 
one-half days of the experiment but this was largely due to the 16.0 
pounds gained by Holstein No. 5 during this period. 
The average bodyweight gains of group E were depressed slightly 
below the initial weight for the first nine and one-half days. During 
the remainder of the experiment, these calves grew at a rate similar to 
that observed in group c. The calves in group E exhibited a greater 
gain in weight than the control calves during the last four and one-half 
days of the study. 
The amounts of hay and starter consumed by all animals in experiment I 
were relatively small and there was very little difference in the total 
consumption among all groups in the trial. The average starter consump-
tion for the animals in experiment I was as follows: group A, 8.J lb.; 
group B, 5.9 lb.; group C, 5.6 lb.; group D, 9.6 lb.; and group E, 5.2 lb. 
The calves in group D had the greatest average hay consumption of 5.6 lb. 
followed in descending order by group B with 5.2 lb.; group A, 4.8 lb.; 
and groups C and E with 4.6 lb. each. 
The animals in group D consumed a greater amount of starter than 
the calves in group A and gained more in bodyweight. Whereas the controls 
in group A consumed more starter than group B but did not gain as l!Dlch 
in bodyweight. The control calves also consumed more starter than groups 
C and E but gained at approximately the same rate. It would appear that 
a better utilization of feed occurred in group B. Due to the small 
amounts of feed consumed and the variations in the different groups, it 
. is probable that little significance should be attached to dry feed 
consumption. 
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The average milk consumption of all animals was nearly constant 
with the exception of group Gin which the amount consumed was about 
10.0 pounds less per calf. This was apparently due to a greater incidence 
of scouring in this group and ~ore frequent reductions in milk intake 
for the purpose of scour control. 
A summary of-all cases of scours is presented in Table II. Although 
scours were not considered a problem in this study, there was less 
scouring observed in those groups receiving aureomycin by oral admin-
istration. Groups Band D had 2 and 4 eases of scours observed,respect-
ively, while groups A and~ had 6 cases each and group G, 9 cases for 
the four-week-period. Of all the cases observed in experiment I, only 
four required medication. 
The second experiment in this study was designed so as to have five 
calves in each of the five groups. Due to the limited number of calves 
that could be obtained in the time availablef only preliminary data on 
four calves in each group will be reported here. 
Preliminary data from experiment II are presented in Appendix 
Tables 6 through 10 and are summarized in Table III. The control animals 
lost one pound the first two days, but gained in weight at a steady rate 
thereafter, although they never attained the increase in bodyweight 
observed in any of the groups receiving aureomycin. 
The calves in group D receiving 70 mg. of aureomycin per day made 
average daily gains of 0.65 pounds as compared to 0.32 pounds for the 
controls. Groups F and H receiving 500 mg. and 125 mg.,respectively, 
in single oral doses per week made average daily gains of 0.41 pounds 
each for the four week trial. The calves in group F receiving 250 mg. 
weekly by intramuscular injection also exhibited an average daily gain 
of 0.41 pounds. 
Group 
A. 
B 
C 
D 
E 
_____;_ 
. Table II 
Th-e E!'f"eet uf Au-reonzy cfn !~ -Orally -~ f>-1!!.i'-ent~ere.11y 
Upon the Incidence, Duration and Severity or Scours 
During the First 4 Weeks of Life, .Ex:periment I 
Number of Average Number of Treatment 
Cases scours duration Cases requiring 
·Per Group of Treatment 
Sc·ouring 
(days) 
6 3 .. 8 None None 
2 5 1 1000 mg. A.ureo., 
9 4/3 l 500 mg. _ Aureo. 
4 4.2 2 1500 mg. Aureo. 
6 2.8 None None 
Group __ 
A. 
D 
F 
G 
H 
Table III 
The Effect of Aureomycin Administered Orally and Parenterally Upon 
Growth and Feed Gonsmnption of Dairy Calves During the First 4 Weeks of Life, 
Ex:periment II 
A.v~l'§.ge growth gains by 4 weeks Average Feed. Consumed by 4 weeks 
-Ave. Ave. Gain _Ave. Gain Ave. Gain Mille starter Hay 
~itial 
.. 
in in Rt. at· in Chest 
Weight Bodyweight Withers Gireumf erence 
(lb.) (lb.) (inches) (inches) (lb.) (lb.) (lb") 
77.5 9.0 1.50 1.00 167.5 7.2 8.5 
76.7 18.2 0.87 1.75 175_.l 12 .. 7 7.7 
79.7 ll.5 2.12 1 .. 25 _116 .. 1 9.3 6.9 
71.7 11.5 1.70 1.25 163.5 8.7 8.9 
74.7 11.7 1.12 1.12 1-69.5 9.5 8.,7 
I' 
C 
.. 
The calves in group D exhibited the most uniform growth curve 
after the first two days as can be observed from Figure 2. These animals 
lost an average of one pound for the first two days then grew at a rapid 
and uniform rate for the remainder of the trial. 
No gain was observed for the first nine days in group F, but a 
fairly constant gain of about 3.0 pounds per week prevailed from the 
ninth day until the trial terminated. When comparing group F to the 
control animals, it can be seen that there was a delay at the beginning 
of the growth curve as measured by average gain in bodyweight. The 
animals in group F gained less than any group on the experiment during 
the first sixteen days, but f rom the twenty~second day until the terJnc-
ination of the trial t hese animals gained at a more rapid rate than any 
of the other groups. 
Calves in group G lost an average of 2.0 pounds the first two days 
of the trial. During the following week~ these animals gained at a rate 
of 4.2 pounds, but from the tenth through the seventeenth day, these 
calves lost an average or 0.75 pounds apiece. Two of the four calves in 
this group gained a total of 9.0 pounds but the other two lost a total 
of 12.0 pounds. During the remainder of the experiment these animals 
gained at a rather constant rate. 
There were considerable fluctuations in the average gain in height 
at withers and gain in chest circumference. Group F had the greatest 
increase in height at withers 1 but was largely due to the 3o0 inch gain 
of Holstein No. 161. Group G had a greater increase in height at withers 
than the controls, while groups D and H both had smaller increases than 
the control calves . 
The average gain in chest circumference was greater for all the 
groups receiving aureomycin t han it was for the controlso Group D 
27. 
2i 
Group A Group D 
20 20 
E-1 
ffi 
15 H 15 f,:j ~ 
A 0,...... 
10 CQ • 10 ..a 
z ... ~ 
H'-' 
z 
5 
H 5 <it d 
. 
ri:I 
0 l> 0 < 
0 1 2 3 4 5 0 1 2 3 4 5 
Group F Group G 
20 20 
15 15 
5 5 
0 0 
0 
20 
15 
10 
5 
0 
0 
1 2 
Group H 
.~ 
l 2 
4 
3 
5 
1 
I 
I 
I 
0 l 2 J 4 5 
FIGURE 2 
COMP A.RISON OF GROWTH AS MEASURED 
BY A.VE. WEEKLY GAIN IN BOD~EIGHT 
FROM THE INITIAL TO THE FINAL WEI~ 
exhibited the greatest increase in chest eircru.mf'erence of 1.75 incheso 
Milk consumption for all groups was relatively oonstanto The groups 
receiving aureonwcin eonsu.mied more starter than the controls, 'With group 
D consuming the greatest amount. Hay consumption wa~ small im all groups 
and very little individual differences among groups prevailed. !he hay 
consumptions varied from 8.9 lb. in group G to 6.9 lh. in group F. 
0 
Scours again were not a problem in this experiment; only five cases 
occurred and they were not severe, with only one requiring treatment. 
Two c~ses occurred in groups A and F and one ease in group D0 
Group 
D 
F 
Ta'IJle IV 
The Ef.f ect oi" Aureomycin A.dniiniste:red Orally' a:p.d Parente:i:-al.Iy 
Upon the Incidence., Duration and Seve:d.ty of Scours 
· Durip.g the First 4 Weeks of Lite, Experiment II 
Calf 
N.o .. 
G-86 
G-9 (b) 
G-135 
G-23 
No,. Cases 
of 
Scours 
1 
l 
1 
1 
1 
Duration 
of 
Scouring 
(days) 
2 
; 
3 
2 
2 
Treatment 
None 
500 mg. Aureo 
None 
None 
None 
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DISCUSSION 
The results obtained in experiment I indicate that 70 mg. of 
aureom1cin administered daily was effective in increasing the bodyweight 
fains of dairy calves from birth to four weeks of age. These findings 
are in agreement with previous study at this station. The calves 
rec'eiving 70 mg. of aureomycin gained .36% more in bodyweight than the · 
control calves for the four week period. The greatest acceleration in 
' 
growth of this aureomycin group over the controls was observed from the 
ninth day until term1:nation of :the trial. 
The oral admin:istration· of 250 mg. of aureomycin in a: single weekly 
dose resulted in a .1g1'owth response .similar to that observed when 70 mg. 
was administered daily. · ,The calves in this group actually presented a 
more desirable growth .curve. than .did_the 70 mg. group. The group 
receiving 250 mg. gained at a constant rate from the initial weighing 
whereas the initiation of growth was slightly delayed in the group 
receiving 70 mg. This lag in the growth curve of group D was largely 
due to the 10 pound loss in bodyweight of Guernsey number. 9 ( a). during 
the first two days o.f the trial •. 
Calves in group C receiving 60 mg. of aureomycin weekly by implant 
had slightly lower bodyweight gains than the controls. Group Chad a ' 
higher incidence of scouring than the controls as well as a longer average 
duration of each case of scours. This might account for lower bodyweight 
gains observed. 
Group E, which received 60 mg. of aureomycin weekly by intramuscuJar 
injection had average daily bodyweight gains of 0.08 pounds less than the 
controls. The incidence of scouring in this group paralleled that 
observed in the control group. The fact that the calves in group E had 
a higher initial bodyweight of approximately 4.0 pounds more than the 
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controls may partially explain the slower rate of gain in bodyweight 
made by group E. 
It appears from the data that no beneficial results were obtained 
from the subcutaneous implantation nor the intramuscular injection of 
60 mg. of aureomycin under the conditions of this experiment. It was 
not possible to determine how much time was required for the aureomycin 
pellets to be absoFbed into the blood stream after implantation. The 
pellets may have been absorbed at a rate which was too slow to 
facilitate concentrations which would be sufficiently high to be effective 
in stimulating growth. There is also a possibility that the level of 
antibiotic administered was too lowo It would appear that this latter 
observation may have partially been the reason for the lack of response 
in the injected group, since preliminary results from experiment II 
indicate that a growth stimulation may result from higher levels of 
injection. 
There has not been a very accurate method developed for measuring 
the skeletal growth of cattle. The major measurements used for esti-
mating skeletal growth are height at withers and chest circumference. 
This method is subject to error, especially when used on young calves 
for a relatively short period. The small changes that did occur in 
the measurements of chest circumference and height at withers in this 
study could have been due to an increase in flesh rather than an 
increased skeletal growth. Although very little difference was observed 
in the skeletal growth of the calves in experiment I, there was a 
tendency for slightly greater increases in the calves receiving oral 
administrations of aureomycin. Since the skeletal structure may 
increase only one or two inches during the first month of life, it is 
probable that little significance shoul~ be placed upon the changes 
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observed during the period of this study. 
During the first month of life calves exist basically upon milk. 
When dry feed is offeredj small amounts may be consumed but the individ-
ual consumption will vary. An illustration of the variation in starter 
consumption can be noted from group B, in which Guernsey No. 1 consumed 
6.1 pounds and Guernsey No. 3 consumed only 2.9 pounds for the four weeks. 
The calves in all groups consumed relatively small amounts of both hay 
and starter and it would appear that little significance could be placed 
upon any differences in feed consumption between treatment groups. 
It was observed that there was a tendency for a slightly lower 
incidence of scours in all groups of calves receiving aureomycin by oral 
administration. This latter observation might tend to indicate that 
growth may have been partially stimulated by the control of scours, since 
a higher growth rate was obtained in those calves receiving oral adminis-
trations of aureomycin. 
Although less scouring was observed in groups Band D, scours were 
not considered a problem in any of the groups due to the low incidence 
and mildness in nature. It appeared that most cases of scours that did 
occur were associated with errors in management and were not particularly 
related to the experimental treatments. This latter observation is 
substantiated by the fact that during the course of this study there 
were two definite periods when wet sawdust was inadvertantly used to bed 
the calves. It was during these two periods that the most serious out-
breaks of scours occurred. During the early part of experiment I, when 
the first supply of wet sawdust was used, eight of eleven calves on 
trial at that time developed eleven cases of scours which persisted for 
an average of 4.2 days. Three of the cases required medication while the 
remainder were controlled by reducing the milk intake by one-half for a 
33, 
few days. 
Dry sawdust was obtained following this outbreak of scours. During 
the succeeding two and one-half months, eight of sixteen calves developed 
scours of only 2.0 days average duration. All eases were mild in nature 
and all responded to reduced milk intake with no medication. 
Wet sawdust was inadvertantly used to bed the calves a second time 
.. 
and six of the seven calves in the barn at that time developed scours 
immediately. The bedding situation was remedied at once and the scour 
outbreak was broug~t under control very quickly, but not before one of 
the six calves had required medication. 
' ' 
Even though there .was a slight tendency for less scouring iin the 
groups receiving oral administrations of aureoJeycinll it should not be 
concluded that the eo~lete grovth· ,stiJmlatiom observed·_ in this study 
resulted from the co:ttt,r.Gl,:~f 'SC0tlt$~ {While this may have .. been partially 
r~sponsible for thEkbfu1efits ;observed 0:at would. appear likely·:·,that other· .. 
factors were involvalll .. 
The levels or· a-iU=itr~t:Lon:.,were. altered in,,. the seeond::e~eriment 
to determine the er,~i:rt~: ,tjf,.· a•,-hilgbli3r•,parenteral .adlun1stra1iion- ,as well 
as both higher and ,:U.>wer.: lle~lclly:s,·:oral :·.ad.min.istra.tions~,,1 :Th!s . '$tti.ey has not 
~· ., 
been completed and ·onil1:·.preliminary data are presented in this report.· 
It should. be noted tlaa;l';;.wh11Eh'thesefrcalve1;1 we:re\managed,-the0same and ,kept 
in the same stalls BJ:1 the .calves,ibit•experiment-I,.-·.thULs:tudy,"vas conducted 
during the spring 11i'e~stm whil~_/liheifttr,st exper1-n:t.:, was. tjatr;i.ed!-: on dur~g· 
the fall and winteP :mo;itbs._': 
Preliminary datA frc:un .... the A,1e.cOI1.c:Lstudy re.veral~,,t~t .the. calves 
receiv:i,ng 70 ~. of @.Ur,~omycin,by.daily oral administratic,n.made twice as. 
great average daily bodyweight g~inS.,fls the cpntrol,,calvei:1.,, ';this suppprts 
the results obtain~d ~ a:x.periment I and is in accordance with previous 
results at this station when the average daily gain of calves receiving 
70 mg. aureomycin was twice that observed in the controls during the first 
five weeks of life. 
Preliminary observations on calves receiving 125 or 500 mg. in 
single weekly oral doses indicate that while a growth response was 
observed neither of these levels were as effective as 70 mg. administered 
daily. In comparing these weekly levels to the 250 mg. oral administration 
in experiment I, it should be noted that a higher increase in growth rate 
was obtained when 250 mgo was given than when either 125 or 500 mg. were 
administeredo This would appear to indicate that 125 mg. was too low a 
level to cause a marked stimulation in growth rate, while 500 mg. in a 
single oral dose may have been too great a level at one administration to 
allow an optimum growth response. 
By observing groups F and D a comparison can be obtained between the 
administration of 500 mg. aureomycin in a single weekly oral dose and the 
administration of 490 mg. when given in seven equal daily doses for a week. 
The calves in. group D receiving 70 mg. daily gained an average of 6.7 lb. 
more for the four week trial than the calves in group F receiving the 
500 mg. in a single weekly dose. This appears to indicate that there is 
an optimum level that can be administered during weekly intervals to 
obtain the best growth response. 
Preliminary results indi~ate that an increased growth rate may result 
from weekly intramuscular injections of 250 mg. of aureomycin. This 
latter observation would not preclude the intestinal tract as the site 
of aureomycin activity since work with humans has demonstrated that 
aureomycin is readily re-excreted into the gastro-intestinal tract. 
There was an unexplainable lag in the growth curve of the calves in 
group G from the tenth through the seventeenth day. 
Comparison of this group to group Bin experiment I in which the 
calves received 250 mg. by oral administration show that the oral dosage 
produced a much greater growth stimulation over the controls than that 
when the same amount was injected. 
The gain in height at withers and gain in chest ci~eumference was 
small in all groups. It would appear that small unavoidable errors in 
measuring may have had more effect on the observed differences than did 
experimental treatments. The average gain in chest circumference was 
greater in all calves receiving aureomycin. 
The milk and hay consumption were relatively constant for all groups. 
More starter was consumed by the animals receiving aureomycin than by the 
controls. The calves receiving 70 mg. or aureomycin daily consumed the 
greatest amount or starter which might be expected since they had consid-
erable higher daily gainso 
A summary of the scours occurring in the second experiment are 
presented in Table IV. Scours appeared to have little, if any, effect 
on the results obtained in this experiment, since only five eases occurred 
in the twenty calves on trialo The calves in groups A and F exhibited 
two eases of scours each and one ease occurred in group D. Only one 
ease in group A required medication while .the other calves responded to 
reductions in milk intakeo 
36. 
SUMMARY 
Studies were conducted to determine the effects of different levels 
or aureomycin when administered orally, subcutaneously, mid intramus-
.cularly, upon the growth rate, feed consumption, and general health or 
dairy calves during the first four weeks of life. 
The oral administration or 70 mg. or aureomycin daily or the oral 
administration or 250 mg. in a single dose weekly appeared to stimnlate 
an increase in the rate or gain in bodyweight. Although errors in 
management probably were more directly associated with scours than 
experimental treatments, there was a slightly lower incidence of scours 
observed in the two groups receiving oral administration of aureomycin. 
The skeletal growth as measured by height at withers and chest circum-
ference was slightly greater in the groups receiving aureomycin orally. 
It is probable that little significance should be attached to these 
gains observed in skeletal growth since al;J. changes were small and might 
not necessarily represent an accurate measure or skeletal growth. 
On the basis of preliminary data it appears that while a growth 
response was observed" neither 125 nor 500 mg. or aureomycin in single 
oral weekly dosesw.aile as effective as 70 mg. admini~tered daily. 
There were no apparent growth benefits obtained by weekly intra-
muscular injections nor subcutaneous implantations or 60 mg. of 
aureomycin. Neither were these levels of any apparent value in reducing 
the incidence or severity or scours. Prelinµ,n.~ry results indicate, 
however, that an increased growth rate may r~su;Lt from weekly intra-
muscular injections of 250 mg. or aureiomyc:i,n. 
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PA.GE 
44 
45 
46 
47 
48 
49 
50 
51 
52 
Calf Bodl!!ei ght 
Noo Initial Gain 
(lb.) 
G=-14 55 + 10 
G..4 72 + 9 
G-8 69 + 8 
G-17 75 ,. 4 
A~2 77 + 10 
A-8 70 .. 20 
H-111 96 + 19 
I 73.4 + ll.4 
Table I 
Growth and Feed Consumption Records of. Galves 
Receiving no Aureomycin, Eicperiment I 
GROUP A 
Ht. at Withers Chest Cir. 
Initial Gain Initial Gain 
(in.) (in.) 
26.5 + 1.0 25.5 + 1.5 
Z7.0 + 1.0 28.0 -t 1.0 
28.5 + 1.0 28.5 + 1.5 
28.0 + 1.0 28.,0 4 1.0 
Z7 .. 5 + 1.5 28.0 .:, 1.0 
26.0 + 2.5 2s.o + 2.0 
29.0 .,o. 1.5 30.5 + 1.5 
Z7.5 + 1.35 28.0 + 1.35 
Feed ConsumEtion 
Mille Starter Hay 
(lb.) 
119.0 3.3 3 .. 2 
166.5 5.2 3.9 
165.5 6.5 5.2 
J.5640 4.6 2.5 
158.0 11.7 4.7 
156.3 9.4 4.4 
233.0 17.4 9.4 
164.9 8.30 4.75 
j:: 
• 
Calf 
Bo. 
G-1 
G-,;J 
G-10 
A-3 
G-18 
A-10 
. 
H-9 
'!"" 
X 
TABLE 2 
--Growth and Feed Consumption Records of Calves 
Receiving 250 mg. A.ureomycin Orally per Week, Experiment I 
GROUP B 
Bod;t!eifl!t Ht. at Withers Chest Cir• 
Initial Gain Initial Gain Initial Gain 
(lb.) {in.) {in.) 
74 • 25 30.0 + 2.0 29.0 + 1._5 
61 + 1 Zl.O + 1.0 Zl.5 .. o.o 
85 + 11 .30.0 + 1.0 30.5 + o.o 
74 + ll Z1.5 + 1.0 zr.o + 2.0 
80 + 12 28.o .. 2.0 28.0 • 3.0 
(I} 
• 19 Z1.0 + 2.0 Zl.5 • 2.5 
68 • 32 26.0 • 2.0 28.0 .. 4.0 
73.0 + 15.8 Zl.9 + 1.~ 28.2 .. 1.ss 
Feed GonsumEtion 
Mllk starter 
{1b.) 
1«}2.0 6.1 
- 100.5 2.9 
187.5 5.7 
168.0 5.0 
170.0 3.6 
168.0 9.5 
172.0 8.6 
165.4 5.91 
Bay 
7.2 
4.2 
4.1 
4.9 
4.4 
6.7 
4.6 
5~1§ 
~ 
Vt 
• 
Cal:t 
No. 
G-13 (a) 
G-2 
G-7 
G-.12 
.. . A.-6 
. H-5 
A-13 
X 
Table 3 
Growth and Feed Consumption Records o:t Calves 
Receiving 60 mg. Aureomycin by Implant Weekly, Experiment I 
GROUP C 
Botl.u!eigat Hto at Withers Chest Cir1 
Initial Gain Initial Gain Initial Gain 
(lb.) (in.) (in.) 
75 + 9 28.0 + 1.0 30.0 • 1.0 
65 + 9 28.5 • 1.0 28.0 + 1.0 
57 .. 8 25.5 + 1.0 26.5 + 1.0 
74 .. 9 29.0 + 1.0 Z'! .5 • 3.0 
90 + 10 29.5 o.o 30.5 + 2.0 
'17 + 16 29.0 • 1.5 30.0 • 1.0 
78 + 15 Z'!. 5 + 1.0 29.0 + 0.5 
76.5 + 10.8 28.1 + 0.92 28.7 +1.35 
Feed Consum.Etion 
Milk Starter Hay 
(lb.) 
151.0 6.7 5.8 
132.0 3.4 3.8 
105.0 2.5 1.6 
166.0 2..7 2.8 
179.0 4.7 3.1 
204.0 12.5 9.8 
140.5 6.6 5.1 
153.9 5.58 4.57 
~ 
"" 
Calf 
No., 
G-15 
G-5 
!-1 
G-9 (a) 
G-19 
A.-7 
H-J4 
X 
Table 4 
Growth and Feed Consumption Records of Calves 
Receiving 70 mgo Aureomycin Daily by Oral Administration, Experiment I 
GROUP D 
Bodl!:!eight Ht1 at Withers Chest Cir, Feed ConsumEtion 
Initial Gain Initial Gain Initial Gain Milk Starter 
(lbo) (in.) (in.) (lbo) 
70 ,. 17 26 .. 0 .+ lo5 24.5 + 3.0 1.37 .5 6 .. 3 
75 + 20 28.0 + 2o0 Z7 o5 + 2.0 149.5 13o0 
67 + 11 26.5 • 0 .. 5 28.0 + 2.0 164 .. 5 7 .. 0 
69 + 7 Zl .. 5 + 1.5 Zl.O + 0.5 161.0 10 .. 0 
105 + 6 Zl .5 + l.5 Zl .-5 + 1.0 147.5 4.5 
64 + 19 28.0 +_lo5 28.5 + 2.0 168.0 10.5 
69 + 25 29.5 + 2.5 Jl.O + 2.0 229.0 16.2 
74.1 + 15.0 Zl .5 + 1. tj7 Zl.7 + 1.78 165.2 9.64 
Hay 
4o9 
4.4 
J.7 
4.8 
508 
4.6 
11.1 
5.61 
~ 
" 
Table 5 
Growth and Feed Consumption Record~ of Calves 
Receiving (:f) mg. Aureomycin Intramuscn,Il.arlf per Week, Experiment I 
GROUPE 
Calf Bod;n!eiggt Ht, at Withers Chest Cir, Feed ConsumEtion 
No. Initial Gain Initial qain Initial Gain Milk Starter Hay 
(lb.) (in.) (in.) (lb.) 
G-16 71 .. ll 30.0 + 1.0 28.0 + l_.5 155.0 7.0 7.0 
G-6 71 + 10 28.0 + 1.0 Zl .5 + 2.0 158.0 5. 5 4.0 
G-11 70 0 Zl.O o.o Zl.O o.o 125.0 4.6 2.5 
G-21 88 + 5 29.0 + 1.0 30.5 + 0.5 179.5 2.2 1.3 
A-5 77 + 15 28.0 + 2.0 30.0 + 1.5 170.5 3.8 4.7 
H-3 94 + 16 29.5 o.o 31.0 + 2.0 2CJ7.1 5.9 5.2 
A-11 70 .. 7 26.5 + 2.0 Zl.5 + 2.0 167.5 7.5 7.3 
X 77.2 + 9.1 28.2 + LOO 28.7 + l.;35 166.0 5.21 4.57 
~ 
0 
.Calf 
. No. 
G-22 
H-1 
--
G-86 
G-9 (b) 
-X 
--- --··-- - -· 
Bod:vweigat·. 
Initial Gain 
(lb.) 
81 + 10 
75 + 22 
64 0 
90 .. 4 
77.5 + 9.0 
Table 6 
Growth and Feed Consumption Beeords of Calves 
Receiving no A.ureomyein, Experiment II 
GROUP A 
Ht1 at Withers Chefi!t Cir1 
Initial Gain Initial Gain 
(in.) {in.) 
29.0 .e, 2.5 30.0 + 1.0 
Zl .5 + 1.0 29.0 + 1.5 
Zl .5 + 1.0 Zl.O + 1.0 
29.0 + 1.5 29.5 + 0.5 
28.2 + 1.50 28.8 + 1.00 
Feed Consum~tion 
Milk Starter Hay 
(lb.) 
178.5 4.8 6.6 
180.0 6.6 5.4 
135.0 7.3 9.1 
177.0 10.2 12.0 
l&/.5 7.22 8.52 
~ 
• 
Calf 
No. 
G-24 
A-15 
A-16 
G-108 
-X 
Table 7 
Growth and Feed Consumption Records of Calves 
Receiving 70 mg. Aureomycin Daily by Oral Administration, Experiment II 
GROUP D 
Bocl!!,!eight Ht:1 at Withers Chest Cira Feed Consum£tion 
Initial Gain Initial Gain Initial Gain Mille Starter Hay 
(lb.) (in.) (in.) (lb.) 
69 + 24 'Z1. 5 + 1.0 28.5 + 2.5 151.5 14o5 5 .. 3 
90 + 11 28.5 o.o 29.5 .. 1.0 lo/'/ .O 7o5 5.8 
76 + 22 26.5 + 2.0 28.0 + 2.5 170.,5 18.0 8.8 
72 + 16 29.0 + 0.5 28.5 + 1.0 181.5 1008 11.0 
76o7 + 18.2 'Z1 .8 + o.87 28.,6 + 1.75 175.l 12.,7 7.72 
\J\ 
0 
0 
Calf 
No. 
G=23 
G--135 
G-1.3 (b) 
H-161 
X 
Table 8 
Growth and Feed Consumption Records of Calves 
Receiving 500 mgo Aureomycin Orally per Week, Ex:periment II 
GROUP F 
Bod~eight Hto at ,Withers Chest Cir 
Initial Gain Initial Gain Initial Gain 
(lb.) (ino) (ino) 
99 + 15 290 5 4> 2.,5 31,,0 4 1 .. 5 
60 + 6 26.,0 + 2.0 2600 ~ 2.,0 
82 .a. 12 2800 + 1.0 28.0 ~ 0 .. 5 
78 + 13 Zl.O ~ 3.0 29.0 ~ 1 .. 0 
79o7 + 11 .. 5 Zl.,6 et 2.12 Zl.,6 + 1 .. 25 
Feed ConsumEtion 
Milk Starter Hay 
(lb0 ) 
222..0 1306 4ol 
127 o5 602 4o5 
167.,0 9o5 7,.0 
19100 s .. o 12 .. 1 
176 .. 8 9 .. .32 6092 
VI 
I-' 
• 
Calf 
Noo 
G-140 
G-l'Z/ 
A-177 
G-96 
X 
Table 9 
Growtli and Feed Consumption Records of Galves 
Receiving 250 mg., Aureomycin Intramuscularly per Week1 Experiment II 
GROUP G 
B6d;n!eigat. Ht 11 at Wither§ Che§t Cir11 Feed Consum~tion 
I:pitial Gain Initial Gain Initial Gain Milk Starter 
(lb .. ) (in.) (ino) (lbo) 
76 + 19 26.5 + 1.0 28.0 ~ 1.5 181.5 1208 
61 + 7 26.0 ~ 2.0 26 .. 0 .:. 1.5 132.5 4o4 
75 + 12 'Z1 .o + lco5 29.0 + Oo5 171.0 9 .. 6 
75 .. 8 'Z/ o5 al, 2o5 28.5 "" 1. 5 169.0 7 ,,.9 
71.7 + 11.5 26 .. 7 + 1.75 'Zl.7 + 1.25 163.5 8 .. 87 
Hay 
12.0 
3.4 
10.6 
9.5 
8.87 
Vt 
I\.) 
• 
Calf 
No. 
G-29 
G-165 
A-17 
A.-140 
-X 
Table 10 
Growth and Feed Consumption Records of Galves 
Receiving 125 mgo Aureomycin Orally per Week, Experiment II 
GROUP H 
~,.:,dl!ei~t Hto at Withers Chest Ci;r. 
Initial Gain Initial Gain Initial Gain 
(lbo) (in.) (in .. ) 
78 .. 14 28.5 .. 1.0 28.0 + 1.5 
62 + 14 Zl,.5 + 1.5 Zl.5 • 1.5 
88 + 16 28.5 + 1.0 30.5 + 1.0 
75 + 3 26 .. 5 .a, 1.0 28.5 + 0.5 
74.4 + 11.7 'Zl.7 + 1.12 28 .. 5 + 1.12 
Feed GonsumEtion 
Milk Starter 
(lb.) 
168.0 11.9 
144.8 6.6 
190.0 10.3 
176.o 9.0 
i69.5 9.45 
Hay 
8.2 
7.8 
6.7 
12.1 
8.70 
VI 
~ 
• 
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